Medpace Holdings (MEDP) Tops Q3 EPS by 6c; Boosts FY16 Outlook

Medpace Holdings (NASDAQ: MEDP) reported Q3 EPS of $0.40, $0.06 better than the analyst estimate of $0.34. Revenue for the quarter came in at $94.8 million versus the consensus estimate of $91.42 million.

GUIDANCE:

Medpace Holdings sees FY2016 EPS of $1.51-$1.56, versus the consensus of $1.45. Medpace Holdings sees FY2016 revenue of $368-371 million, versus the consensus of $365.1 million.

For earnings history and earnings-related data on Medpace Holdings (MEDP) click here.

You May Also Be Interested In

• Gilead Sciences (GILD) Misses Q1 EPS by 288c
• FICO (FICO) Tops Q2 EPS by 33c, provides guidance
• Skechers USA (SKX) Tops Q1 EPS by 23c, Beats on Revenue; Offers FY24 Guidance